Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Myrtle has various health benefits and potential for medicine development.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Ruxolitinib can help regrow hair in severe alopecia areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

The book explains the science of tissue repair and regeneration, its medical uses, challenges, and ethical concerns.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.